ReviewJournal of comparative effectiveness research2025
Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience.
Chakrapani Balijepalli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.